Henry Christian O's Form 4/A amendment
AmendedPacific Biosciences of California, Inc. (PACB) · filed Sep 20, 2021
- Accession no.
- 0001299130-21-000204
- Filed
- Sep 20, 2021
- Trade date
- Sep 16, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 17, 2021
This filing lists 1 non-derivative transaction. Open-market sales total $2.44M. It was filed 4 days after the trade.
This amendment replaces 0001299130-21-000198 (filed Sep 17, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henry Christian OCIK 0001263805 | Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | Common Stock | SSaleDisposed | −90,520 | $26.91F2 | −$2,435,893.2 | 674,480 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- F2
This sale price represents the weighted average sale price of the shares sold ranging from $26.72 to $27.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4/A.
Referenced by the price of 1 transaction in Table I.